vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $142.9M, roughly 1.9× Piedmont Realty Trust, Inc.). Enhabit, Inc. runs the higher net margin — -14.3% vs -30.3%, a 16.0% gap on every dollar of revenue. On growth, Enhabit, Inc. posted the faster year-over-year revenue change (4.7% vs -0.3%). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -0.6%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
EHAB vs PDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $142.9M |
| Net Profit | $-38.7M | $-43.2M |
| Gross Margin | — | — |
| Operating Margin | -12.3% | — |
| Net Margin | -14.3% | -30.3% |
| Revenue YoY | 4.7% | -0.3% |
| Net Profit YoY | 15.9% | -44.3% |
| EPS (diluted) | $-0.76 | $-0.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $142.9M | ||
| Q3 25 | $263.6M | $139.2M | ||
| Q2 25 | $266.1M | $140.3M | ||
| Q1 25 | $259.9M | $142.7M | ||
| Q4 24 | $258.2M | $143.2M | ||
| Q3 24 | $253.6M | $139.3M | ||
| Q2 24 | $260.6M | $143.3M | ||
| Q1 24 | $262.4M | $144.5M |
| Q4 25 | $-38.7M | $-43.2M | ||
| Q3 25 | $11.1M | $-13.5M | ||
| Q2 25 | $5.2M | $-16.8M | ||
| Q1 25 | $17.8M | $-10.1M | ||
| Q4 24 | $-46.0M | $-30.0M | ||
| Q3 24 | $-110.2M | $-11.5M | ||
| Q2 24 | $-200.0K | $-9.8M | ||
| Q1 24 | $200.0K | $-27.8M |
| Q4 25 | -12.3% | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | -16.0% | — | ||
| Q3 24 | -38.6% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | 4.9% | — |
| Q4 25 | -14.3% | -30.3% | ||
| Q3 25 | 4.2% | -9.7% | ||
| Q2 25 | 2.0% | -12.0% | ||
| Q1 25 | 6.8% | -7.1% | ||
| Q4 24 | -17.8% | -20.9% | ||
| Q3 24 | -43.5% | -8.3% | ||
| Q2 24 | -0.1% | -6.8% | ||
| Q1 24 | 0.1% | -19.2% |
| Q4 25 | $-0.76 | $-0.34 | ||
| Q3 25 | $0.22 | $-0.11 | ||
| Q2 25 | $0.10 | $-0.14 | ||
| Q1 25 | $0.35 | $-0.08 | ||
| Q4 24 | $-0.92 | $-0.25 | ||
| Q3 24 | $-2.20 | $-0.09 | ||
| Q2 24 | $0.00 | $-0.08 | ||
| Q1 24 | $0.01 | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $731.0K |
| Total DebtLower is stronger | $426.0M | $2.2B |
| Stockholders' EquityBook value | $534.0M | $1.5B |
| Total Assets | $1.2B | $4.0B |
| Debt / EquityLower = less leverage | 0.80× | 1.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $731.0K | ||
| Q3 25 | $56.9M | $3.0M | ||
| Q2 25 | $37.1M | $3.3M | ||
| Q1 25 | $39.5M | $2.9M | ||
| Q4 24 | $28.4M | $109.6M | ||
| Q3 24 | $45.7M | $133.6M | ||
| Q2 24 | $28.5M | $138.5M | ||
| Q1 24 | $36.5M | $3.5M |
| Q4 25 | $426.0M | $2.2B | ||
| Q3 25 | $441.5M | $2.2B | ||
| Q2 25 | $456.9M | $2.2B | ||
| Q1 25 | $467.3M | $2.2B | ||
| Q4 24 | $492.6M | $2.2B | ||
| Q3 24 | $502.9M | $2.2B | ||
| Q2 24 | $512.7M | $2.2B | ||
| Q1 24 | $526.7M | $2.1B |
| Q4 25 | $534.0M | $1.5B | ||
| Q3 25 | $566.8M | $1.5B | ||
| Q2 25 | $552.4M | $1.5B | ||
| Q1 25 | $543.2M | $1.6B | ||
| Q4 24 | $523.5M | $1.6B | ||
| Q3 24 | $566.1M | $1.6B | ||
| Q2 24 | $674.3M | $1.7B | ||
| Q1 24 | $672.3M | $1.7B |
| Q4 25 | $1.2B | $4.0B | ||
| Q3 25 | $1.2B | $4.0B | ||
| Q2 25 | $1.2B | $4.0B | ||
| Q1 25 | $1.2B | $4.0B | ||
| Q4 24 | $1.2B | $4.1B | ||
| Q3 24 | $1.3B | $4.1B | ||
| Q2 24 | $1.4B | $4.2B | ||
| Q1 24 | $1.4B | $4.0B |
| Q4 25 | 0.80× | 1.49× | ||
| Q3 25 | 0.78× | 1.43× | ||
| Q2 25 | 0.83× | 1.41× | ||
| Q1 25 | 0.86× | 1.40× | ||
| Q4 24 | 0.94× | 1.40× | ||
| Q3 24 | 0.89× | 1.36× | ||
| Q2 24 | 0.76× | 1.34× | ||
| Q1 24 | 0.78× | 1.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $140.6M |
| Free Cash FlowOCF − Capex | $3.3M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $140.6M | ||
| Q3 25 | $37.8M | $35.8M | ||
| Q2 25 | $10.6M | $50.1M | ||
| Q1 25 | $17.9M | $3.7M | ||
| Q4 24 | $-4.1M | $198.1M | ||
| Q3 24 | $28.4M | $42.9M | ||
| Q2 24 | $9.6M | $66.8M | ||
| Q1 24 | $17.3M | $23.4M |
| Q4 25 | $3.3M | — | ||
| Q3 25 | $36.2M | — | ||
| Q2 25 | $8.7M | — | ||
| Q1 25 | $17.6M | — | ||
| Q4 24 | $-4.7M | — | ||
| Q3 24 | $27.7M | — | ||
| Q2 24 | $8.9M | — | ||
| Q1 24 | $15.5M | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 13.7% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | -1.8% | — | ||
| Q3 24 | 10.9% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 5.9% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | 3.41× | — | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 86.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
PDM
| Atlanta GA | $45.7M | 32% |
| Dallas TX | $24.1M | 17% |
| Orlando FL | $19.3M | 13% |
| New York NY | $14.7M | 10% |
| Northern Virginia Washington D.C. | $12.9M | 9% |
| Minneapolis MN | $11.4M | 8% |
| Boston MA | $9.8M | 7% |
| Real Estate Other | $7.8M | 5% |
